Altıntaş, Y.E.; Bilici, A.; Yıldız, Ö.; Kınıkoğlu, O.; Ölmez, Ö.F.
The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Medicina 2025, 61, 865.
https://doi.org/10.3390/medicina61050865
AMA Style
Altıntaş YE, Bilici A, Yıldız Ö, Kınıkoğlu O, Ölmez ÖF.
The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Medicina. 2025; 61(5):865.
https://doi.org/10.3390/medicina61050865
Chicago/Turabian Style
Altıntaş, Yunus Emre, Ahmet Bilici, Özcan Yıldız, Oğuzcan Kınıkoğlu, and Ömer Fatih Ölmez.
2025. "The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer" Medicina 61, no. 5: 865.
https://doi.org/10.3390/medicina61050865
APA Style
Altıntaş, Y. E., Bilici, A., Yıldız, Ö., Kınıkoğlu, O., & Ölmez, Ö. F.
(2025). The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Medicina, 61(5), 865.
https://doi.org/10.3390/medicina61050865